Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger

Acta Tropica

Volumn 128, Issue 2, 2013, Pages 318-325

  Garba, Amadou ^a,b,c   Lamine, Mariama S ^a   Djibo, Ali ^d   Tahirou, Almoustapha ^d   Aouami, Mahamadou Aboubacar ^d   Alfari, Aichatou ^e   Phillips, Anna E ^f   Fenwick, Alan ^f   Utzinger, Jürg ^b,c  

^a Reseau International Schistosomoses Environnement Aménagement et Lutte ^*  (Niger)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITÉ ABDOU MOUMOUNI   (Niger)

^e Programme National de Lutte contre la Bilharziose et les Geohelminthes   (Niger)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Efficacy; Niger; Praziquantel; Preschool aged children; Safety; Schistosoma haematobium; Schistosoma mansoni; Schistosomiasis; Syrup formulation

Indexed keywords

EPIQUANTEL; PRAZIQUANTEL; UNCLASSIFIED DRUG;

CHEMOTHERAPY; CHILD HEALTH; DIARRHEAL DISEASE; DISEASE PREVALENCE; DISEASE TREATMENT; PARASITIC DISEASE; SAFETY; VILLAGE;

ABDOMINAL PAIN; ARTICLE; BLOODY DIARRHEA; CHILD; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FECES ANALYSIS; FEMALE; FEVER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NIGERIA; PARASITE IDENTIFICATION; PRESCHOOL CHILD; QUESTIONNAIRE; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; SOMNOLENCE; TREATMENT OUTCOME; URINALYSIS; VOMITING;

NIGER [NIGERIA]; NIGERIA;

SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI;

EFFICACY; NIGER; PRAZIQUANTEL; PRESCHOOL-AGED CHILDREN; SAFETY; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SYRUP FORMULATION;

ADMINISTRATION, ORAL; ANIMALS; ANTHELMINTICS; CHEMOPREVENTION; CHILD, PRESCHOOL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FECES; FEMALE; HUMANS; INFANT; MALE; NIGER; PRAZIQUANTEL; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; TREATMENT OUTCOME; URINE;

EID: 84885483284     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2012.12.003     Document Type: Article

References (42)

1. Bergquist R., Johansen M.V., Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when?. Trends Parasitol. 2009, 25:151-156.
2. Botros S., El-Lakkany N., Seif el-Din S.H., Sabra A.N., Ibrahim M. Comparative efficacy and bioavailability of different praziquantel brands. Exp. Parasitol. 2011, 127:515-521.
3. Castro N., Medina R., Sotelo J., Jung H. Bioavailability of praziquantel increases with concomitant administration of food. Antimicrob. Agents Chemother. 2000, 44:2903-2904.
4. Coulibaly J.T., N'Gbesso Y.K., Knopp S., Keiser J., N'Goran E.K., Utzinger J. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium. PLoS Negl. Trop. Dis. 2012, 6:e1917.
5. Dabo A., Badawi H.M., Bary B., Doumbo O.K. Urinary schistosomiasis among preschool-aged children in Sahelian rural communities in Mali. Parasit. Vectors 2011, 4:21.
6. Doenhoff M.J., Cioli D., Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 2008, 21:659-667.
7. Ekpo U.F., Laja-Deile A., Oluwole A.S., Sam-Wobo S.O., Mafiana C.F. Urinary schistosomiasis among preschool children in a rural community near Abeokuta, Nigeria. Parasit. Vectors 2010, 3:58.
8. Ekpo U.F., Oluwole A.S., Abe E.M., Etta H.E., Olamiju F., Mafiana C.F. Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control. Parasitology 2012, 139:835-841.
9. Fenwick A., Webster J.P., Bosque-Oliva E., Blair L., Fleming F.M., Zhang Y., Garba A., Stothard J.R., Gabrielli A.F., Clements A.C.A., Kabatereine N.B., Toure S., Dembele R., Nyandindi U., Mwansa J., Koukounari A. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 2009, 136:1719-1730.
10. Garba A., Alarou A. Situation des schistosomoses au Niger. La lutte contre les schistosomoses en Afrique de l'Ouest 2000, 215-224. Éditions IRD, Paris. J.-P. Chippaux (Ed.).
11. Garba A., Barkire N., Djibo A., Lamine M.S., Sofo B., Gouvras A.N., Bosque-Oliva E., Webster J.P., Stothard J.R., Utzinger J., Fenwick A. Schistosomiasis in infants and preschool-aged children: infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger. Acta Trop. 2010, 115:212-219.
12. Garba A., Labbo R., Tohon Z., Sidiki A., Djibrilla A. Emergence of Schistosoma mansoni in the Niger River valley, Niger. Trans. R. Soc. Trop. Med. Hyg. 2004, 98:296-298.
13. Garba A., Lamine M., Barkire N., Djibo A., Sofo B., Gouvras A., Labbo R., Sebangou H., Webster J.P., Fenwick A., Utzinger J. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger. Acta Trop. 2013, 128:334-344.
14. Garba A., Pion S., Cournil A., Milet J., Schneider D., Campagne G., Chippaux J.P., Boulanger D. Risk factors for Schistosoma haematobium infection and morbidity in two villages with different transmission patterns in Niger. Acta Trop. 2010, 115:84-89.
15. Garba A., Toure S., Dembele R., Bosque-Oliva E., Fenwick A. Implementation of national schistosomiasis control programmes in West Africa. Trends Parasitol. 2006, 22:322-326.
16. Gray D.J., Ross A.G., Li Y.S., McManus D.P. Diagnosis and management of schistosomiasis. BMJ 2011, 342:d2651.
17. Gryseels B. Schistosomiasis. Infect. Dis. Clin. North Am. 2012, 26:383-397.
18. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev. Inst. Med. Trop. São Paulo 1972, 14:397-400.
19. Keiser J., Ingram K., Utzinger J. Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Parasitology 2011, 138:1620-1632.
20. King C., Abassi I., Sturrock R.F., Muchiri E., Karuiki C., Hamburger J. Towards schistosomiasis transmission control and elimination: can snail prepatent infection rate serve as an indicator of residual transmission potential?. Am. J. Trop. Med. Hyg. 2006, 75:213.
21. Kjetland E.F., Leutscher P.D., Ndhlovu P.D. A review of female genital schistosomiasis. Trends Parasitol. 2012, 28:58-65.
22. Meyer T., Sekljic H., Fuchs S., Bothe H., Schollmeyer D., Miculka C. Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment. PLoS Negl. Trop. Dis. 2009, 3:e357.
23. Midzi N., Sangweme D., Zinyowera S., Mapingure M.P., Brouwer K.C., Kumar N., Mutapi F., Woelk G., Mduluza T. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:759-766.
24. Navaratnam A.M., Sousa-Figueiredo J.C., Stothard J.R., Kabatereine N.B., Fenwick A., Mutumba-Nakalembe M.J. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children with observation on compliance and safety. Trans. R. Soc. Trop. Med. Hyg. 2012, 106:400-407.
25. Odogwu S.E., Ramamurthy N.K., Kabatereine N.B., Kazibwe F., Tukahebwa E., Webster J.P., Fenwick A., Stothard J.R. Schistosoma mansoni in infants (aged<3 years) along the Ugandan shoreline of Lake Victoria. Ann. Trop. Med. Parasitol. 2006, 100:315-326.
26. Olds G.R. Administration of praziquantel to pregnant and lactating women. Acta Trop. 2003, 86:185-195.
27. Olliaro P.L., Vaillant M.T., Belizario V.J., Lwambo N.J., Ouldabdallahi M., Pieri O.S., Amarillo M.L., Kaatano G.M., Diaw M., Domingues A.C., Favre T.C., Lapujade O., Alves F., Chitsulo L. A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40mg/kg vs 60mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLoS Negl. Trop. Dis. 2011, 5:e1165.
28. Rollinson D., Knopp S., Levitz S., Stothard J.R., Tchuem Tchuenté L.A., Garba A., Mohammed K.A., Schur N., Person B., Colley D.G., Utzinger J. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013, 128:423-440.
29. Savioli L., Gabrielli A.F., Montresor A., Chitsulo L., Engels D. Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19. Parasitology 2009, 136:1677-1681.
30. Schur N., Hürlimann E., Garba A., Traore M.S., Ndir O., Ratard R.C., Tchuem Tchuenté L.A., Kristensen T.K., Utzinger J., Vounatsou P. Geostatistical model-based estimates of schistosomiasis prevalence among individuals aged≤20 years in West Africa. PLoS Negl. Trop. Dis. 2011, 5:e1194.
31. Sousa-Figueiredo J.C., Betson M., Stothard J.R. Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole. Int. Health 2012, 4:95-102.
32. Sousa-Figueiredo J.C., Pleasant J., Day M., Betson M., Rollinson D., Montresor A., Kazibwe F., Kabatereine N.B., Stothard J.R. Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int. Health 2009, 2:103-113.
33. Stoever K., Molyneux D., Hotez P., Fenwick A. HIV/AIDS, schistosomiasis, and girls. Lancet 2009, 373:2025-2026.
34. Stothard J.R., Gabrielli A.F. Schistosomiasis in African infants and preschool children: to treat or not to treat?. Trends Parasitol. 2007, 23:83-86.
35. Stothard J.R., Chitsulo L., Kristensen T.K., Utzinger J. Control of schistosomiasis in sub-Saharan Africa: progress made, new opportunities and remaining challenges. Parasitology 2009, 136:1665-1675.
36. Stothard J.R., Sousa-Figueiredo J.C., Betson M., Green H.K., Seto E.Y., Garba A., Sacko M., Mutapi F., Vaz Nery S., Amin M.A., Mutumba-Nakalembe M., Navaratnam A., Fenwick A., Kabatereine N.B., Gabrielli A.F., Montresor A. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitology 2011, 138:1593-1606.
37. Talaat M., Miller F.D. A mass chemotherapy trial of praziquantel on Schistosoma haematobium endemicity in Upper Egypt. Am. J. Trop. Med. Hyg. 1998, 59:546-550.
38. Utzinger J., Raso G., Brooker S., de Savigny D., Tanner M., Ørnbjerg N., Singer B.H., N'Goran E.K. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 2009, 136:1859-1874.
39. WHO Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech. Rep. Ser. 2002, 912:1-57.
40. WHO Promoting safety of medicines for children 2007, World Health Organization, Geneva, 59 pp.
41. WHO Schistosomiasis: population requiring preventive chemotherapy and number of people treated in 2010. Wkly. Epidemiol. Rec. 2012, 87:37-44.
42. Yewale V.N., Dharmapalan D. Promoting appropriate use of drugs in children. Int. J. Pediatr. 2012, 2012:906570.